Background: With the development of continuous glucose monitoring systems (CGMS),
detailed glycemic data are now available for analysis. Yet analysis of this data-rich …

Background: Variations in blood glucose levels over a given time interval is termed as
glycemic variability (GV). Higher GV is associated with higher diabetes-related …

Background: Many glycemic variability (GV) indices exist in the literature. In previous works,
we demonstrated that a set of GV indices, extracted from continuous glucose monitoring …

Estimation of glycemic variability requires frequent measures of glucose and is greatly aided
by continuous glucose monitoring (CGM); however, under real-world conditions, missing …

The dynamic complexity of the glucose–insulin metabolism in diabetic patients is the main
obstacle towards widespread use of an artificial pancreas. The significant level of subject …

Background Patients with diabetes are prone to asymptomatic hypoglycemia (AH) due to
diminished ability to perceive the onset of hypoglycemia. However, the actual prevalence …

Objective: Glycemic variability (GV) is an important component of overall glycemic control for
patients with diabetes mellitus. Physicians are able to recognize excessive GV from …

Teneligliptin is a novel peptidomimetic-chemotype prolylthiazolidine-based inhibitor of
dipeptidyl peptidase-4 (DPP-4). The aim of this study was to evaluate the effects of …

Impaired glucose tolerance, glucose fluctuations, and hypoglycemia have been observed in
patients with chronic liver disease (CLD). The flash glucose monitoring (FGM) system, which …

Continuous glucose monitoring (CGM), while a relatively new technology, has the potential
to transform care for children with type 1 diabetes. Some, but not all studies, have shown that …